Recent discussions surrounding the U.S. approach to combatting the fentanyl crisis have highlighted the complex dynamics involving Canada and China. Despite claims that Canada plays a significant role in fentanyl trafficking, fact checks indicate that it only accounts for 0.2% of U.S. border fentanyl seizures. Former President Trump has faced criticism for linking Canada to the crisis, as many experts argue that tariffs are not a viable solution to the drug epidemic. As the U.S. imposes new tariff threats aimed at curbing the flow of illicit drugs, the effectiveness of these measures remains uncertain, with some analysts suggesting that they may actually lead to lower fentanyl prices. The conversation about tariff impacts takes center stage against the backdrop of a national security crisis, prompting calls for more comprehensive strategies to address the issue of synthetic opioids originating from China and trafficked into the U.S.